↓ Skip to main content

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

Overview of attention for article published in BMC Cancer, December 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
2 X users
patent
3 patents

Citations

dimensions_citation
66 Dimensions

Readers on

mendeley
99 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
Published in
BMC Cancer, December 2012
DOI 10.1186/1471-2407-12-615
Pubmed ID
Authors

Ulf Petrausch, Petra C Schuberth, Christian Hagedorn, Alex Soltermann, Sandra Tomaszek, Rolf Stahel, Walter Weder, Christoph Renner

Abstract

Asbestos is the main cause of MPM in industrialized countries. Even since asbestos is banned in most developed countries, the peak wave of MPM incidence is anticipated for the next years due to the long latency of asbestos induced MPM. MPM patients not eligible for surgical procedures like decortication or pleuro-pneumectomie have a median survival of 12 months with palliative chemotherapy. Therefore, new therapeutic approaches are of crucial need in this clinical situation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
Belgium 1 1%
Unknown 95 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 21%
Student > Ph. D. Student 15 15%
Student > Bachelor 12 12%
Professor 5 5%
Other 5 5%
Other 16 16%
Unknown 25 25%
Readers by discipline Count As %
Medicine and Dentistry 25 25%
Agricultural and Biological Sciences 18 18%
Biochemistry, Genetics and Molecular Biology 12 12%
Immunology and Microbiology 7 7%
Unspecified 2 2%
Other 9 9%
Unknown 26 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2022.
All research outputs
#6,482,068
of 22,986,950 outputs
Outputs from BMC Cancer
#1,665
of 8,353 outputs
Outputs of similar age
#69,067
of 281,637 outputs
Outputs of similar age from BMC Cancer
#26
of 116 outputs
Altmetric has tracked 22,986,950 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 8,353 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 281,637 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.